Different structural requirements within the switch II region of the Ras protein for interactions with specific

S A Moodie1, M Paris, E Villafranca

  • 1Dept. Mole. Biology, Bristol Myers & Squibb Research Institute, Princeton, New Jersey 08543, USA.

Oncogene
|August 3, 1995
PubMed

Insights

Ras protein interactions with effectors like Raf-1 are modulated by the Switch II region. Mutations impact binding to guanine nucleotide exchange factors, PI-3 kinase, and neurofibromin, affecting signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Protein Interactions

Background:

  • Ras proteins are key regulators of cellular signaling pathways.
  • Ras-GTP forms specific complexes with downstream effectors, including Raf-1, B-raf, PI-3 kinase, and RalGDS.
  • These interactions are crucial for signal transduction and are dependent on the Ras effector binding domain (Switch I region).

Purpose of the Study:

  • To investigate the role of the Ras Switch II region (amino acids 60-72) in mediating stable interactions with downstream effector proteins.
  • To determine how specific point mutations in the Switch II region affect Ras binding affinity and downstream signaling.
  • To elucidate the competitive binding dynamics between Ras effectors and negative regulators like neurofibromin.

Main Methods:

  • Site-directed mutagenesis was used to introduce point mutations into the Ras Switch II region.
  • In vitro binding assays were performed to assess the affinity of wild-type and mutant Ras proteins for various effector proteins (Raf-1, B-raf, PI-3 kinase, RalGDS) and regulators (guanine nucleotide exchange factors, neurofibromin).
  • Enzyme activity assays (MEK1, MAP kinase) were conducted to evaluate the functional consequences of altered Ras-effector interactions.

Main Results:

  • Mutations at positions 65 or 64 in the Switch II region impaired the interaction of nucleotide-free Ras with guanine nucleotide exchange factors.
  • Specific mutations (e.g., at positions 65 and 71) enhanced the affinity of Ras for B-raf and MEK1 activation.
  • Other Switch II mutations (e.g., at position 64 with 65 or 71) disrupted binding to PI-3 kinase and neurofibromin while maintaining interaction with Raf-1 and B-raf.
  • An activated Ras mutant (Q61L-Ras) bound all effectors irrespective of nucleotide-bound state, and Q61L-Ras-GDP effectively activated MEK1 and MAP kinase.
  • Competitive binding studies revealed that neurofibromin's interaction with Ras is mutually exclusive with Raf-1 and B-raf binding.

Conclusions:

  • The Switch II region of Ras proteins plays a critical role in determining effector specificity and interaction stability.
  • Specific mutations in Switch II can selectively alter Ras binding to different downstream targets, impacting signaling outcomes.
  • Ras-GTP complexed with Raf-1 or B-raf may be resistant to downregulation by rasGAP and neurofibromin, suggesting a mechanism for sustained signaling.
  • These findings provide insights into the intricate regulation of Ras signaling pathways and their modulation by effector interactions.

Related Concept Videos

Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...